pituitrin has been researched along with Urinary-Incontinence* in 6 studies
6 other study(ies) available for pituitrin and Urinary-Incontinence
Article | Year |
---|---|
Therapeutic effect and mechanism of polysaccharide from Alpiniae oxyphyllae fructus on urinary incontinence.
The purpose of this paper was to investigate the effects and mechanism of polysaccharide (PAOF) from Alpiniae oxyphyllae fructus on urinary incontinence (UI) in old-age hydruric model rats (OHMR). Results suggested that PAOF can significantly reduce the urination volume, Na Topics: Adenylyl Cyclases; Aldosterone; Alpinia; Amino Acids, Cyclic; Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Fruit; Gene Expression Regulation; Polysaccharides; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-3; RNA, Messenger; Urinary Incontinence; Vasopressins | 2019 |
Plasma antidiuretic hormone levels in children with spina bifida.
Urological management of spina bifida patients is controversial. The goals of therapy of neurogenic bladder are continence, prevention of infections and preservation of urinary tract. Desmopressin has been recently used in a spina bifida population that is dry during the day (daytime continence was achieved with clean intermittent catheterization and anticholinergics) but wet at night. The aim of this study was to assess plasma antidiuretic hormone (ADH) levels in these children.. The study included 24 patients, 11 males and 13 females (mean age 6.4 years) referred to the Spina Bifida Centre of the Catholic University of Rome, and 57 normal age-matched controls. Morning (07.30-08.00 h) plasma ADH levels were measured using a specific radioimmunoassay.. Plasma ADH levels (normal range 5-11 microg/l) did not differ between spina bifida population and healthy controls. Serum ADH had a mean of 6.8 microg/l in affected children and a mean of 7.4 microg/l in the controls.. We conclude that the use of desmopressin in children with spina bifida should be reserved only in patients with decreased secretion of ADH, or may be useful in patients with persistent nocturnal incontinence to reduce night wetting. Therefore, research with a larger population is needed. Topics: Child; Child, Preschool; Deamino Arginine Vasopressin; Female; Humans; Male; Meningomyelocele; Radioimmunoassay; Spinal Dysraphism; Urinary Incontinence; Vasopressins | 2002 |
Urinary incontinence in elderly patients.
Topics: Aged; Humans; Urinary Incontinence; Vasopressins | 1997 |
The relationship between the bladder, the kidneys and the CNS.
Topics: Central Nervous System; Circadian Rhythm; Enuresis; Humans; Kidney; Monitoring, Physiologic; Pressure; Urinary Bladder; Urinary Incontinence; Urination Disorders; Vasopressins | 1995 |
Acute intermittent porphyria with inappropriately elevated ADH secretion.
Topics: Acute Disease; Adult; Ataxia; Barbiturates; Consciousness Disorders; Craniocerebral Trauma; Electroencephalography; Epilepsy; Female; Humans; Hyponatremia; Nystagmus, Pathologic; Porphobilinogen; Porphyrias; Urinary Incontinence; Vasopressins; Water-Electrolyte Balance | 1974 |
Basis of nocturnal polyuria in patients with autonomic failure.
Five dysautonomic patients with the Shy-Drager syndrome were studied to determine the basis of their nocturnal polyuria. The results indicated excessive postural modification of renal function in dysautonomic patients. This may, in fact, relate to excessive release of ADH while these patients are up and about, and excessive inhibition while they are recumbent. Treatment with vasopressin produced an inconsistent response. Topics: Aged; Circadian Rhythm; Dysautonomia, Familial; Evaluation Studies as Topic; Fecal Incontinence; Female; Humans; Hydrocortisone; Hypotension, Orthostatic; Kidney; Male; Middle Aged; Nervous System Diseases; Osmolar Concentration; Parkinson Disease; Posture; Potassium; Sodium; Syndrome; Urinary Incontinence; Vasopressins; Water Deprivation | 1974 |